Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
World Neurosurgery
|
May 21, 2021
Trends in Academic Misrepresentation in Neurological Surgery Residency Applicants: A 2-Year Analysis
Vijay Letchuman, Daniel L Barrow, David Cory Adamson
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
April 26, 2003
Background gradient suppression in pulsed gradient stimulated echo measurements
Phillip Zhe Sun, John Georg Seland, David Cory
Health & Social Work
|
June 7, 2016
Technology's Promise to Elders
Catheleen Jordan, David Cory, Scott Sainato, et al.
Expert Opinion on Investigational Drugs
|
July 30, 2019
The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential
Casey Anthony, Nikol Mladkova-Suchy, David Cory Adamson
Expert Opinion on Investigational Drugs
|
October 12, 2020
Emerging and investigational targeted chemotherapy and immunotherapy agents for metastatic brain tumors
J Tanner McMahon, Razan R Faraj, David Cory Adamson
Australasian Journal on Ageing
|
March 8, 2019
The use of opioids for chronic non-cancer pain in older Australians
Michael David Cory O'Brien, Anne Pamela Frances Wand, Brian Draper
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
March 9, 2011
Low-frequency NMR with a non-resonant circuit
Timothy Hopper, Soumyajit Mandal, David Cory, et al.
World Neurosurgery
|
December 20, 2014
Radiation-induced malignant gliomas: a current review
Aladine A Elsamadicy, Ranjith Babu, John P Kirkpatrick, et al.
International Journal of Oncology
|
September 24, 2015
OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways
Jing Li, Chunhui Di, Jenny Jing, et al.
International Journal of Oncology
|
May 9, 2014
Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review)
Liang Zeng, Brian E Fee, Miriam V Rivas, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
World Neurosurgery
|
May 21, 2021
Trends in Academic Misrepresentation in Neurological Surgery Residency Applicants: A 2-Year Analysis
Vijay Letchuman, Daniel L Barrow, David Cory Adamson
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
April 26, 2003
Background gradient suppression in pulsed gradient stimulated echo measurements
Phillip Zhe Sun, John Georg Seland, David Cory
Health & Social Work
|
June 7, 2016
Technology's Promise to Elders
Catheleen Jordan, David Cory, Scott Sainato, et al.
Expert Opinion on Investigational Drugs
|
July 30, 2019
The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential
Casey Anthony, Nikol Mladkova-Suchy, David Cory Adamson
Expert Opinion on Investigational Drugs
|
October 12, 2020
Emerging and investigational targeted chemotherapy and immunotherapy agents for metastatic brain tumors
J Tanner McMahon, Razan R Faraj, David Cory Adamson
Australasian Journal on Ageing
|
March 8, 2019
The use of opioids for chronic non-cancer pain in older Australians
Michael David Cory O'Brien, Anne Pamela Frances Wand, Brian Draper
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
March 9, 2011
Low-frequency NMR with a non-resonant circuit
Timothy Hopper, Soumyajit Mandal, David Cory, et al.
World Neurosurgery
|
December 20, 2014
Radiation-induced malignant gliomas: a current review
Aladine A Elsamadicy, Ranjith Babu, John P Kirkpatrick, et al.
International Journal of Oncology
|
September 24, 2015
OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways
Jing Li, Chunhui Di, Jenny Jing, et al.
International Journal of Oncology
|
May 9, 2014
Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review)
Liang Zeng, Brian E Fee, Miriam V Rivas, et al.
Page
of 3